Clinical application of combined detection of procalcitonin and highsensitivity Creactive protein in bacterial infection in elderly patients with coronary heart disease

Abstract:

ObjectiveTo compare changes in infectious markers in blood of patients with coronary heart disease (CHD), analyze clinical diagnostic value of procalcitonin (PCT) and highsensitivity Creactive protein (hsCRP) in bacterial infection in patients with  CHD. MethodsPatients with CHD admitted to a hospital between January 2013 and December 2014 were studied. PCT, hsCRP, white blood cell (WBC), and neutrophil (NEU) count were detected before treatment and on the 5th day after treatment, differences between bacterial infected group and noninfected group, infection sites, as well as survival and death groups were compared respectively. ResultsSerum levels of PCT,hsCRP,WBC, and NEU in bacterial infected group were all significantly higher than noninfected group; PCT and hsCRP in infection of different sites were statistically significant （all P<0.001）, patients with bloodstream infection had the highest levels (［45.148±46.341］ ng/mL, ［137.000±87.367］mg/L, respectively)，followed by thoracic and abdominal infection,as well as respiratory system infection，while patients with urinary system infection had the lowest levels(［0.769±1.747］ng/mL, ［53.006±45.450］mg/L, respectively). After treatment, makers in survival group were all lower than before treatment, but in death group were all higher than before treatment. The area under the curve of PCT, hsCRP, WBC, and NEU were 0.934, 0.856, 0.782, and 0.784 respectively. ConclusionThe combined detection of PCT and hsCRP is effective for early diagnosis of bacterial infection in elderly patients with CHD, it is also helpful for assessing disease condition, curative efficacy, and prognosis.

Key words:

procalcitonin;highsensitivity Creactive protein;coronary heart disease;bacterial infection;diagnosis;prognosis